ALIVUS LIFE SCIENCES
Back to Balance Sheet
|
ALIVUS LIFE SCIENCES Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,754 Cr | ₹3,528 Cr | ₹3,220 Cr | ₹2,834 Cr | ₹2,221 Cr |
What is the latest Total Liabilities ratio of ALIVUS LIFE SCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹3,754 Cr |
| Mar2024 | ₹3,528 Cr |
| Mar2023 | ₹3,220 Cr |
| Mar2022 | ₹2,834 Cr |
| Mar2021 | ₹2,221 Cr |
How is Total Liabilities of ALIVUS LIFE SCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,754 Cr | 6.39 | |
| Mar2024 | ₹3,528 Cr | 9.55 | |
| Mar2023 | ₹3,220 Cr | 13.65 | |
| Mar2022 | ₹2,834 Cr | 27.62 | |
| Mar2021 | ₹2,221 Cr | - | |
Compare Total Liabilities of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹14,054.1 Cr | -1.9% | 7.2% | 5.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | -1.9% |
7.2% |
5.6% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses